Intermolecular (IMI) Tops Q2 Loss Views by 1c; Issues Mixed Q3 Outlook
Tweet
Share
E-mailGet Alerts IMI Hot Sheet
Join SI Premium – FREE
Intermolecular (NASDAQ: IMI) reported Q2 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $14.88 million.
Intermolecular sees Q3 2012 EPS of $-0.02-$-0.01, versus the consensus of $0.01. Intermolecular sees Q3 2012 revenue of $15.5-$16.0 million, versus the consensus of $14.85 million.
For earnings history and earnings-related data on Intermolecular (IMI) click here.
Intermolecular sees Q3 2012 EPS of $-0.02-$-0.01, versus the consensus of $0.01. Intermolecular sees Q3 2012 revenue of $15.5-$16.0 million, versus the consensus of $14.85 million.
For earnings history and earnings-related data on Intermolecular (IMI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
